Initial Molecular Mechanisms of the Pathogenesis of Parkinson’s Disease in a Mouse Neurotoxic Model of the Earliest Preclinical Stage of This Disease
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25021354 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Anna Kolacheva und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neural and Neuroendocrine Regulations, Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, 119334 Moscow, Ru…. Hauptthemen laut MEDLINE: Parkinson Disease, Neurotoxicity Syndromes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Ministry of Science and Higher Education of the Russian Federation, IDB RAS Government.
Abstract (Originalsprache)
Studying the initial molecular mechanisms of the pathogenesis of Parkinson’s disease (PD), primarily in the nigrostriatal dopaminergic system, is one of the priorities in neurology. Of particular interest is elucidating these mechanisms in the preclinical stage of PD, which lasts decades before diagnosis and is therefore not available for study in patients. Therefore, our main goal was to study the initial molecular mechanisms of the pathogenesis of PD in the striatum, the key center for dopamine regulation in motor function, in a mouse model of the earliest preclinical stage of PD, from 1 to 24 h after the administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). It was shown that the content of tyrosine hydroxylase (TH), the first enzyme in dopamine synthesis, does not change within 6 h after the administration of MPTP, but decreases after 24 h. In turn, TH activity increases after 1 h, decreases after 3 h, remains at the control level after 6 h, and decreases 24 h after the administration of MPTP. The concentration of dopamine in the striatum gradually decreases after MPTP administration, despite a decrease in its degradation. The identified initial molecular mechanisms of PD pathogenesis are considered as potential targets for the development of preventive neuroprotective treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Neural and Neuroendocrine Regulations, Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, 119334 Moscow, Russia.
ORCID-Profile: Anna Kolacheva, Vsevolod Bogdanov
Förderung
- The Ministry of Science and Higher Education of the Russian Federation
- IDB RAS Government
Zitieren
APA
Kolacheva, A., Pavlova, E., Bannikova, A., Bogdanov, V., & Ugrumov, M. (2024). Initial Molecular Mechanisms of the Pathogenesis of Parkinson’s Disease in a Mouse Neurotoxic Model of the Earliest Preclinical Stage of This Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25021354
Vancouver
Kolacheva A, Pavlova E, Bannikova A, Bogdanov V, Ugrumov M. Initial Molecular Mechanisms of the Pathogenesis of Parkinson’s Disease in a Mouse Neurotoxic Model of the Earliest Preclinical Stage of This Disease. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25021354
BibTeX
@article{Kolacheva2024,
author = {Kolacheva, Anna and Pavlova, Ekaterina and Bannikova, Alyona and Bogdanov, Vsevolod and Ugrumov, Michael},
title = {Initial Molecular Mechanisms of the Pathogenesis of Parkinson’s Disease in a Mouse Neurotoxic Model of the Earliest Preclinical Stage of This Disease},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25021354}
}
EUVIMED